Hyaena hyaena (striped hyena): 120246375
Help
Entry
120246375 CDS
T07257
Symbol
CASP3
Name
(RefSeq) caspase-3 isoform X1
KO
K02187
caspase 3 [EC:
3.4.22.56
]
Organism
hhv
Hyaena hyaena (striped hyena)
Pathway
hhv01524
Platinum drug resistance
hhv04010
MAPK signaling pathway
hhv04115
p53 signaling pathway
hhv04148
Efferocytosis
hhv04210
Apoptosis
hhv04215
Apoptosis - multiple species
hhv04623
Cytosolic DNA-sensing pathway
hhv04650
Natural killer cell mediated cytotoxicity
hhv04657
IL-17 signaling pathway
hhv04668
TNF signaling pathway
hhv04726
Serotonergic synapse
hhv04932
Non-alcoholic fatty liver disease
hhv04933
AGE-RAGE signaling pathway in diabetic complications
hhv04936
Alcoholic liver disease
hhv05010
Alzheimer disease
hhv05012
Parkinson disease
hhv05014
Amyotrophic lateral sclerosis
hhv05016
Huntington disease
hhv05020
Prion disease
hhv05022
Pathways of neurodegeneration - multiple diseases
hhv05132
Salmonella infection
hhv05133
Pertussis
hhv05134
Legionellosis
hhv05145
Toxoplasmosis
hhv05146
Amoebiasis
hhv05152
Tuberculosis
hhv05160
Hepatitis C
hhv05161
Hepatitis B
hhv05162
Measles
hhv05163
Human cytomegalovirus infection
hhv05164
Influenza A
hhv05165
Human papillomavirus infection
hhv05167
Kaposi sarcoma-associated herpesvirus infection
hhv05168
Herpes simplex virus 1 infection
hhv05169
Epstein-Barr virus infection
hhv05170
Human immunodeficiency virus 1 infection
hhv05200
Pathways in cancer
hhv05203
Viral carcinogenesis
hhv05205
Proteoglycans in cancer
hhv05206
MicroRNAs in cancer
hhv05210
Colorectal cancer
hhv05222
Small cell lung cancer
hhv05416
Viral myocarditis
hhv05417
Lipid and atherosclerosis
Brite
KEGG Orthology (KO) [BR:
hhv00001
]
09130 Environmental Information Processing
09132 Signal transduction
04010 MAPK signaling pathway
120246375 (CASP3)
04668 TNF signaling pathway
120246375 (CASP3)
09140 Cellular Processes
09141 Transport and catabolism
04148 Efferocytosis
120246375 (CASP3)
09143 Cell growth and death
04210 Apoptosis
120246375 (CASP3)
04215 Apoptosis - multiple species
120246375 (CASP3)
04115 p53 signaling pathway
120246375 (CASP3)
09150 Organismal Systems
09151 Immune system
04623 Cytosolic DNA-sensing pathway
120246375 (CASP3)
04650 Natural killer cell mediated cytotoxicity
120246375 (CASP3)
04657 IL-17 signaling pathway
120246375 (CASP3)
09156 Nervous system
04726 Serotonergic synapse
120246375 (CASP3)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
120246375 (CASP3)
05206 MicroRNAs in cancer
120246375 (CASP3)
05205 Proteoglycans in cancer
120246375 (CASP3)
05203 Viral carcinogenesis
120246375 (CASP3)
09162 Cancer: specific types
05210 Colorectal cancer
120246375 (CASP3)
05222 Small cell lung cancer
120246375 (CASP3)
09172 Infectious disease: viral
05170 Human immunodeficiency virus 1 infection
120246375 (CASP3)
05161 Hepatitis B
120246375 (CASP3)
05160 Hepatitis C
120246375 (CASP3)
05164 Influenza A
120246375 (CASP3)
05162 Measles
120246375 (CASP3)
05168 Herpes simplex virus 1 infection
120246375 (CASP3)
05163 Human cytomegalovirus infection
120246375 (CASP3)
05167 Kaposi sarcoma-associated herpesvirus infection
120246375 (CASP3)
05169 Epstein-Barr virus infection
120246375 (CASP3)
05165 Human papillomavirus infection
120246375 (CASP3)
09171 Infectious disease: bacterial
05132 Salmonella infection
120246375 (CASP3)
05133 Pertussis
120246375 (CASP3)
05134 Legionellosis
120246375 (CASP3)
05152 Tuberculosis
120246375 (CASP3)
09174 Infectious disease: parasitic
05146 Amoebiasis
120246375 (CASP3)
05145 Toxoplasmosis
120246375 (CASP3)
09164 Neurodegenerative disease
05010 Alzheimer disease
120246375 (CASP3)
05012 Parkinson disease
120246375 (CASP3)
05014 Amyotrophic lateral sclerosis
120246375 (CASP3)
05016 Huntington disease
120246375 (CASP3)
05020 Prion disease
120246375 (CASP3)
05022 Pathways of neurodegeneration - multiple diseases
120246375 (CASP3)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
120246375 (CASP3)
05416 Viral myocarditis
120246375 (CASP3)
09167 Endocrine and metabolic disease
04936 Alcoholic liver disease
120246375 (CASP3)
04932 Non-alcoholic fatty liver disease
120246375 (CASP3)
04933 AGE-RAGE signaling pathway in diabetic complications
120246375 (CASP3)
09176 Drug resistance: antineoplastic
01524 Platinum drug resistance
120246375 (CASP3)
09180 Brite Hierarchies
09181 Protein families: metabolism
01002 Peptidases and inhibitors [BR:
hhv01002
]
120246375 (CASP3)
Enzymes [BR:
hhv01000
]
3. Hydrolases
3.4 Acting on peptide bonds (peptidases)
3.4.22 Cysteine endopeptidases
3.4.22.56 caspase-3
120246375 (CASP3)
Peptidases and inhibitors [BR:
hhv01002
]
Cysteine peptidases
Family C14: caspase family
120246375 (CASP3)
BRITE hierarchy
SSDB
Ortholog
Paralog
GFIT
Motif
Pfam:
Peptidase_C14
Motif
Other DBs
NCBI-GeneID:
120246375
NCBI-ProteinID:
XP_039109781
LinkDB
All DBs
Position
Unknown
AA seq
278 aa
AA seq
DB search
MEGSENSVDAKSIKNSEPRKIFHGSKSMDSGIYLDNSYKMDYPEMGLCIIINNKNFHEST
GMPSRSGTDVDAANLRETFTNLKYEVRNKNDLTREQIVALLDSVSREDHSKRSSFVCVLL
SHGDEGIIYGTNGPLDLKKLTSFFRGDYCRSLTGKPKLFIIQACRGTELDCGIETDSGTE
DDIACQKIPVEADFLYAYSTAPGYYSWRNSKDGSWFIQSLCSMLRLYAHKLEFMHILTRV
NRKVALEFESFSLDSVFHGKKQIPCIVSMLTKELYFYH
NT seq
837 nt
NT seq
+upstream
nt +downstream
nt
atggagggcagtgaaaactcagtggatgcaaaatccattaaaaattcagaacccagaaag
atcttccatggaagcaaatcaatggactccggaatatacttggacaacagttacaaaatg
gattatcctgaaatgggtttatgtataataattaataataagaactttcatgaaagtact
ggaatgccatctcgctctggtacagatgtggatgcggcgaacctccgggaaaccttcaca
aacttgaaatacgaagtcaggaataaaaacgatcttacacgtgaacaaatcgtggcattg
ctggacagtgtgtccagagaagatcatagcaagaggagcagttttgtttgcgtgcttcta
agccacggtgatgaaggaatcatttatggaacaaatggacctcttgacctgaaaaaatta
acaagtttcttcagaggggactattgtagaagtctaaccggcaaacccaaacttttcatt
attcaggcctgtcgaggcacagaactggactgtggcattgagactgacagtggtaccgag
gatgacattgcctgtcagaaaatcccagtggaagccgacttcttatatgcgtattctaca
gcccctggttactactcctggcgaaattccaaggatggatcctggttcatccagtcactt
tgttcgatgctcagactatatgctcacaagcttgagttcatgcacattcttactcgggtt
aaccgaaaggtagctctagaatttgagtccttttctcttgactctgtttttcatggaaag
aaacagattccgtgtattgtatctatgctcacaaaagaactgtatttttatcactaa
DBGET
integrated database retrieval system